Why Badger Meter (BMI) Dipped More Than Broader Market Today

Badger Meter (BMI) recently underperformed the broader market and its sector, closing down 1.08% in the latest session and 1.58% over the past month. Despite forecasts for Q1 EPS growth of 3.7% and revenue growth of 10.25%, with similar double-digit full-year projections, the stock carries a Zacks Rank #4 (Sell) and has seen unchanged consensus EPS estimates over the last 30 days. Furthermore, BMI trades at a Forward P/E of 38.76, representing a notable premium to its industry average of 28.31, indicating potential valuation concerns despite its strong industry group.

Analysis

Badger Meter (BMI) has demonstrated recent market underperformance, with its stock declining 1.08% in the last session and 1.58% over the past month, lagging both the S&P 500 and the Computer and Technology sector. This price weakness contrasts with strong forward-looking estimates, as the company is projected to report a 10.25% year-over-year revenue increase to $229.81 million and a 3.7% EPS increase to $1.12 in its upcoming disclosure. Full-year forecasts are also robust, projecting double-digit growth in both revenue (+11.34%) and earnings (+11.58%). However, several cautionary signals temper this positive outlook. The Zacks Consensus EPS estimate has remained stagnant over the last 30 days, indicating a lack of positive revisions from analysts, which has contributed to a Zacks Rank of #4 (Sell). Furthermore, the stock's valuation appears stretched, trading at a Forward P/E of 38.76, a significant premium to its industry's average of 28.31. While its PEG ratio of 3.22 is in line with the industry, the high P/E suggests that future growth is already heavily priced in. This is noteworthy even as BMI operates within the high-performing Instruments - Control industry, which ranks in the top 12% of all industries.

Key Decisions for Investors

• Investors should exercise caution due to the stock's premium valuation, as its Forward P/E of 38.76 is substantially higher than the industry average, suggesting potential downside risk if growth expectations are not met.
• The upcoming earnings report is a critical catalyst; monitor whether the company achieves its forecasted revenue of $229.81 million and EPS of $1.12, as any shortfall could amplify the recent negative stock performance.
• Given the Zacks Rank of #4 (Sell) and the lack of positive analyst estimate revisions in the past month, it may be prudent to await a shift in analyst sentiment before initiating or adding to positions.
• Consider evaluating other companies within the strong Instruments - Control industry that may offer a more compelling valuation or more favorable near-term catalysts compared to BMI.